169 related articles for article (PubMed ID: 1587618)
1. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.
Warren HS; Glennon ML; Wainwright N; Amato SF; Black KM; Kirsch SJ; Riveau GR; Whyte RI; Zapol WM; Novitsky TJ
Infect Immun; 1992 Jun; 60(6):2506-13. PubMed ID: 1587618
[TBL] [Abstract][Full Text] [Related]
2. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia.
Roth RI; Su D; Child AH; Wainwright NR; Levin J
J Infect Dis; 1998 Feb; 177(2):388-94. PubMed ID: 9466526
[TBL] [Abstract][Full Text] [Related]
3. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor.
Leslie DB; Vietzen PS; Lazaron V; Wasiluk KR; Dunn DL
Surg Infect (Larchmt); 2006 Feb; 7(1):45-52. PubMed ID: 16509785
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
[TBL] [Abstract][Full Text] [Related]
5. A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases.
Vallespi MG; Glaria LA; Reyes O; Garay HE; Ferrero J; Araña MJ
Clin Diagn Lab Immunol; 2000 Jul; 7(4):669-75. PubMed ID: 10882670
[TBL] [Abstract][Full Text] [Related]
6. Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock.
Alpert G; Baldwin G; Thompson C; Wainwright N; Novitsky TJ; Gillis Z; Parsonnet J; Fleisher GR; Siber GR
J Infect Dis; 1992 Mar; 165(3):494-500. PubMed ID: 1538154
[TBL] [Abstract][Full Text] [Related]
7. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
[TBL] [Abstract][Full Text] [Related]
8. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor.
Kloczewiak M; Black KM; Loiselle P; Cavaillon JM; Wainwright N; Warren HS
J Infect Dis; 1994 Dec; 170(6):1490-7. PubMed ID: 7995989
[TBL] [Abstract][Full Text] [Related]
10. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
Schumann RR; Lamping N; Hoess A
J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
[TBL] [Abstract][Full Text] [Related]
11. Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide.
Andrä J; Lamata M; Martinez de Tejada G; Bartels R; Koch MH; Brandenburg K
Biochem Pharmacol; 2004 Oct; 68(7):1297-307. PubMed ID: 15345319
[TBL] [Abstract][Full Text] [Related]
12. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
13. Cyclic Limulus anti-lipopolysaccharide (LPS) factor-derived peptide CLP-19 antagonizes LPS function by blocking binding to LPS binding protein.
Liu Y; Ni B; Ren JD; Chen JH; Tian ZQ; Tang M; Li D; Xia P
Biol Pharm Bull; 2011; 34(11):1678-83. PubMed ID: 22040879
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis.
Andrä J; Howe J; Garidel P; Rössle M; Richter W; Leiva-León J; Moriyon I; Bartels R; Gutsmann T; Brandenburg K
Biochem J; 2007 Sep; 406(2):297-307. PubMed ID: 17501719
[TBL] [Abstract][Full Text] [Related]
15. Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide.
Andrä J; Garidel P; Majerle A; Jerala R; Ridge R; Paus E; Novitsky T; Koch MH; Brandenburg K
Eur J Biochem; 2004 May; 271(10):2037-46. PubMed ID: 15128313
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution.
Hoess A; Watson S; Siber GR; Liddington R
EMBO J; 1993 Sep; 12(9):3351-6. PubMed ID: 8253062
[TBL] [Abstract][Full Text] [Related]
17. A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice.
Vallespi MG; Alvarez-Obregón JC; Rodriguez-Alonso I; Montero T; Garay H; Reyes O; Araña MJ
Int Immunopharmacol; 2003 Feb; 3(2):247-56. PubMed ID: 12586605
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
[TBL] [Abstract][Full Text] [Related]
19. Structure of a synthetic fragment of the LALF protein when bound to lipopolysaccharide.
Pristovsek P; Fehér K; Szilágyi L; Kidric J
J Med Chem; 2005 Mar; 48(5):1666-70. PubMed ID: 15743208
[TBL] [Abstract][Full Text] [Related]
20. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis.
Brandenburg K; Heinbockel L; Correa W; Lohner K
Biochim Biophys Acta; 2016 May; 1858(5):971-9. PubMed ID: 26801369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
